Liver Cirrhosis Completed Phase 2 Trials for Tolvaptan (DB06212)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00479336A Dose-defining Study of OPC-41061 in Treatment of Hepatic EdemaTreatment